Consumers knows omega-3s are good for them, but that’s about all they know on the topic, says the Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City).
SALT LAKE CITY-Consumers knows omega-3s are good for them, but that’s about all they know on the topic, says the Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City).
"Omega-3" is too broad to a term, GOED said, because it refers to three separate fatty acids -- EPA, DHA and ALA -- which do not perform in the same way.
"Consumers don't understand what it is," said Vivian Tysse, sales manager of Denomega (Norway).
ALA (alpha-linolenic acid), derived from plant sources such as flaxseed, can be labeled "omega-3", although it does not have the same nutritional content as EPA and DHA.
"Consumers don't really get the difference...it's EPA and DHA that your body really needs," said Ian Lucas, vice president of innovation and strategy at Ocean Nutrition Canada (Nova Scotia).
"Consumers need to be informed and make their own choice," said Philip Fass, executive director of industry and commercial relations at Martek Biosciences (Columbia, MD).
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.